EP3088397
COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.4.2008EP published:
10.4.2019EP application number:
16165912.3
EPO information:
European Patent Register
Max expiry date:
10.4.2028
Title:
COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER
Timeline
Today
11.4.2008EP application
10.4.2019EP Publication
Owner
Name:
CanBas Co., Ltd.Address:
2-2-1, Otemachi, 410-0801, NumazuShizuoka, JP
Inventor
Name:
KAWABE, TakumiAddress:
Numazu City, JP
Name:
ISHIGAKI, MachiyoAddress:
Numazu City, JP
Name:
SATO, TakujiAddress:
Numazu City, JP
Name:
YAMAMOTO, SayakaAddress:
Shimokanuki, Numazu City, JP
Name:
HASEGAWA, YokoAddress:
Numazu City, JP
Priority
Number:
911258 PDate:
11.4.2007Country:
US
Classification
Categories:
C07D 417/12, A61K 31/427, A61P 35/00